The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Molecular and Cellular Biology

• Publication date

  1988-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/mcb.8.7.2984-2988.1988PMID 2970008PMCID PMC363519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.

  1987cited by this paper
• Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts

  1986cited by this paper
• Lytic and transforming functions of individual products of the adenovirus E1A gene

  1986cited by this paper
• Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene

  1986cited by this paper
• Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials.

  1986cited by this paper
• Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells.

  1986cited by this paper
• Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture

  1985cited by this paper
• The action of oncogenes in the cytoplasm and nucleus.

  1985cited by this paper
• Cancer cells, components of basement membranes, and proteolytic enzymes.

  1985cited by this paper
• Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells.

  1985cited by this paper
• Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation.

  1985cited by this paper
• Differential NK cell and macrophage killing of hamster cells infected with nononcogenic or oncogenic adenovirus.

  1984cited by this paper
• Adenovirus 2 early region 1A stimulates expression of both viral and cellular genes.

  1984cited by this paper
• Malignant transformation of early passage rodent cells by a single mutated human oncogene

  1984cited by this paper
• Adenovirus: transformation and oncogenicity.

  1984cited by this paper
• Complete transformation by adenovirus 2 requires both E1A proteins.

  1984cited by this paper
• Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5

  1984cited by this paper
• The E4 transcriptional unit of Ad2: far upstream sequences are required for its transactivation by E1A.

  1984cited by this paper
• Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity

  1983cited by this paper
• Expression of the large T protein of polyoma virus promotes the establishment in culture of "normal" rodent fibroblast cell lines.

  1983cited by this paper
• Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Cellular oncogenes and multistep carcinogenesis.

  1983cited by this paper
• Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

  1983cited by this paper
• Activation of gene expression by adenovirus and herpesvirus regulatory genes acting in trans and by a cis-acting adenovirus enhancer element.

  1983cited by this paper
• Tumor implantation and invasion at metastatic sites.

  1983cited by this paper
• High efficiency DNA-mediated transformation of primate cells.

  1983cited by this paper
• Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids.

  1982cited by this paper
• The roles of individual polyoma virus early proteins in oncogenic transformation

  1982cited by this paper
• Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.

  1982cited by this paper
• Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.

  1981cited by this paper
• Metastatic potential correlates with enzymatic degradation of basement membrane collagen

  1980cited by this paper
• Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

  1980cited by this paper
• Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.

  1979cited by this paper
• Metastasis results from preexisting variant cells within a malignant tumor.

  1977cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Interactomics: Dozens of Viruses, Co-evolving With Humans, Including the Influenza A Virus, may Actively Distort Human Aging

  2023influential citation
• An oncolytic adenovirus 11p vector expressing adenovirus death protein in the E1 region showed significant apoptosis and tumour-killing ability in metastatic prostate cells

  2019cites this paper
• Development of Therapeutic Genes for Breast Cancer Treatment

  2007cites this paper
• Trials and Tribulations in Developing Clinical Trials of Gene Therapy

  2007cites this paper
• Novel approaches for chemosensitization of breast cancer cells: the E1A story.

  2007cites this paper
• The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity

  2007cites this paper
• Breast cancer gene therapy

  2006cites this paper
• Synergistic Effect of the \-myc Oncogene with H-ras on Radioresistance1

  2006cites this paper
• Enhanced c-erbB2 / neu Expression in Human Ovarian Cancer Cells Correlates with More Severe Malignancy That Can Be Suppressed by EIA 1

  2006cites this paper
• The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers.

  2005cites this paper
• Cancer-specific gene therapy.

  2005cites this paper
• Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer

  2004cites this paper
• Screening mouse mutations for resistance to cancer metastasis

  2004cites this paper
• Strategies to target HER2/neu overexpression for cancer therapy.

  2003cites this paper
• Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16

  2002cites this paper
• E1A Cancer Gene Therapy

  2002cites this paper
• Suppression of tissue factor expression, cofactor activity, and metastatic potential of murine melanoma cells by the N‐terminal domain of adenovirus E1A 12S protein

  2002cites this paper
• E1A: Tumor suppressor or oncogene? Preclinical and clinical investigations ofE1A gene therapy

  2001cites this paper
• HER2 overexpression and cancer targeting.

  2001cites this paper
• E1A is an oncogene and may immortalize normal cells, especially in combination with other oncoproteins.

  2001cites this paper
• Targeting HER2: recent developments and future directions for breast cancer patients.

  2001cites this paper
• Apoptosis: an early event in metastatic inefficiency.

  2001cites this paper
• Transcriptional targeting of the HER-2/neu oncogene.

  2000cites this paper
• E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.

  2000cites this paper
• Apoptosis : An Early Event in Metastatic Inefficiency 1

  2000cites this paper
• Suppressing HER2/neu-Mediated Cell Transformation by Transcriptional Repressors

  2000cites this paper
• Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer.

  2000cites this paper
• The Ras family of GTPases in cancer cell invasion

  2000cites this paper
• E 1 A-mediated Paclitaxel Sensitization in HER-2 / neu-overexpressing Ovarian Cancer SKOV 3 . ip 1 through Apoptosis Involving the Caspase-3 Pathway 1

  2000cites this paper
• Suppression of E1A-Mediated Transformation by the p50E4F Transcription Factor

  1999cites this paper
• Targeting HER-2/neu-Overexpressing Cancer Cells with Transcriptional Repressor Genes Delivered by Cationic Liposome

  1999cites this paper
• Interaction between a Cellular Protein That Binds to the C-terminal Region of Adenovirus E1A (CtBP) and a Novel Cellular Protein Is Disrupted by E1A through a Conserved PLDLS Motif*

  1998cites this paper
• The C terminus of E1A regulates tumor progression and epithelial cell differentiation.

  1998cites this paper
• Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy.

  1998cites this paper
• The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A

  1998cites this paper
• Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus

  1998cites this paper
• Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences

  1997cites this paper
• Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.

  1997cites this paper
• Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.

  1996cites this paper
• Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2.

  1996cites this paper
• Reversal of malignancy by the adenovirus E1a gene.

  1996cites this paper
• Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene.

  1996cites this paper
• Inhibition of intratracheal lung cancer development by systemic delivery of E1A.

  1996cites this paper
• Oncogenes in tumor progression

  1995cites this paper
• HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model.

  1995cites this paper
• Modulation of E-cadherin localization in cells expressing wild-type E1A 12S or hypertransforming mutants.

  1995cites this paper
• The effect of E1A transfection on MMP‐9 expression and metastatic potential

  1995cites this paper
• Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.

  1995cites this paper
• Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2.

  1995cites this paper
• Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation.

  1995cites this paper
• Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.

  1994cites this paper
• Ras-responsive genes and tumor metastasis.

  1993cites this paper
• Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy.

  1993cites this paper
• Adenovirus E1A negatively and positively modulates transcription of AP‐1 dependent genes by dimer‐specific regulation of the DNA binding and transactivation activities of Jun.

  1993cites this paper
• Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.

  1993cites this paper
• Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.

  1993cites this paper
• Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.

  1993cites this paper
• Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.

  1992cites this paper
• Isolation and characterization of a gene encoding rat nucleoside diphosphate kinase.

  1992cites this paper
• Metastatic phenotype of murine tumor cells expressing different cooperating oncogenes

  1992cites this paper
• DNA damage-induced gene expression: signal transduction and relation to growth factor signaling.

  1992cites this paper
• Enhanced invasive properties of rat embryo fibroblasts transformed by adenovirus E1A mutants with deletions in the carboxy-terminal exon.

  1992cites this paper
• Induction and progression of the transformed phenotype in cloned rat embryo fibroblast cells: Studies employing type 5 adenovirus and wild‐type and mutant Ha‐ras oncogenes

  1992cites this paper
• Adenovirus E1a as a tumor-suppressor gene.

  1992cites this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cites this paper
• The influence of the presence of adenovirus 5 E1a and E1b sequences on the pathology of rat embryonic fibroblasts transfected with activated c-Ha-ras and v-ras

  1991cites this paper
• Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A12S gene.

  1991cites this paper
• Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells.

  1990cites this paper
• Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.

  1990cites this paper
• Synergistic effect of the v-myc oncogene with H-ras on radioresistance.

  1990cites this paper
• The role of the H-ras oncogene in radiation resistance and metastasis.

  1990cites this paper
• Genetic regulation of metastatic progression.

  1990cites this paper
• Molecular oncogenetics of metastasis.

  1990cites this paper
• Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes.

  1990cites this paper
• Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

  1990cites this paper
• Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells.

  1989cites this paper
• Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression.

  1989cites this paper
• Oncogenes and tumor progression.

  1989cites this paper
• Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.

  1989cites this paper
• Metastatic conversion of factor-dependent lung fibroblasts (CCL39) requires over-expression of oncogenes which induce high rate of autonomous replication.

  1989cites this paper
• Molecular aspects of the metastatic cascade.

  1989cites this paper
• Oncogenes and metastatic progression.

  1989cites this paper
• Oncogenes and Tumor Progression: State of the Art

  1989cites this paper
• A model to account for the effects of oncogenes, TPA, and retinoic acid on the regulation of genes involved in metastasis

  1988cites this paper